Mount Sinai Medical Center
1 Gustave L Levy Place
New York, New York 10029
Phone: (212) 241-5555
As one of the oldest and largest teaching hospitals in the United States, New York’s Mount Sinai Hospital is committed to providing comprehensive and caring treatment to those patients suffering with mesothelioma. Named after the pioneering mesothelioma researcher who had a long-standing association with Mount Sinai, the Irving J. Selikoff Center for Occupational and Environmental Medicine (COEM) hosts three clinical centers in the metropolitan New York area in order to provide both diagnostic referrals and preventative intervention.
The Selikoff Center conducts educational programs designed to inform building trades workers about the potential for, and hazards of, asbestos exposure in the workplace. The staff works closely with labor unions and employers as well as with government, service and community organizations in order to prevent environmental and work-related illness, and to assist those patients who have already developed such an illness.
Because of the high level of asbestos use in the mid-twentieth century, and the fact that populations exposed to asbestos during that era are now beginning to show symptoms of asbestos-related diseases such as mesothelioma, the number of patients presenting with this disease is increasing. Additionally, the amount of toxic particulate which was released into the air of lower Manhattan following the collapse of the Twin Towers in September 2001 means that many first responders, such as firemen, police and other rescue personnel, are expected to be diagnosed with mesothelioma in the coming years. The Irving J. Selikoff Center for Occupational and Environmental Medicine is one of the primary care facilities for those patients whose respiratory health has suffered as a result of their bravery at Ground Zero.
Internationally known as a Center of Excellence for the prevention, diagnosis and treatment of occupational illnesses, the COEM is funded primarily through multi-year funding grants from the New York State Department of Health.
Mount Sinai boasts a number of other impressive credentials. It ranks in the Top 20 of United States hospitals based on reputation, patient safety and mortality, as compiled by U.S. News and World Report. It ranks 18th in total funding from the National Institutes of Health, and receives an overall total of $252.2 million in grant funding.
Founded in 1852 as “The Jews’ Hospital,” Mount Sinai changed its name ten years later, and has passed a number of important historical milestones in the decades since then. For example, Mount Sinai’s medical school was the first to establish a Department of Geriatrics, as well as to identify a number of diseases, including Crohn’s disease and Tay-Sachs disease. Other firsts associated with Mount Sinai include the first combination application of chemotherapy and radiation to treat both breast and ovarian cancer; the first place to identify the gene for Marfan Syndrome; the first American textbook on thoracic surgery; the first New York State liver transplant; and the first facility to link cigarette smoking with cancer.
Today, Mount Sinai carries on this tradition of innovation and excellence, with a 1,171-bed capacity, over 2,000 attending physicians, and almost 500 medical students. Its facilities and staff provide superlative care to a wide variety of patients, including those who have been stricken by the rare but aggressive cancer mesothelioma.